WEB REGISTRATION CLOSES:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center Danny Crawford, PhDDirector, Nucleic Acid Process Sciences at Intellia TherapeuticsSpeaker
Profile
Danny is Director of Nucleic Acid Process Sciences in the Intellia Tech Ops organization, where he leads pre-clinical and early-phase mRNA and LNP Process Development activities. During his 7 years at Intellia, he has helped drive Intellia’s mRNA process and analytical strategies. Collectively, in both industry and academic roles, he’s focused on RNA biochemistry for the past 20 years.
Agenda Sessions
Chairman’s Remarks: Novel RNA-based Therapeutic and Vaccine Platforms
, 1:55pmView SessionEditing the Genome with Cas9 mRNA
, 2:00pmView Session